Arcellx announces participation at the barclays global healthcare conference

Foster city, calif., march 10, 2022 /prnewswire/ -- arcellx, inc. (nasdaq: aclx), a clinical-stage cell therapy biotechnology company, announced today that chairman and chief executive officer, rami elghandour and chief medical officer, chris heery, m.d.
ACLX Ratings Summary
ACLX Quant Ranking